AstraZeneca PLC ADR falls Monday, still outperforms market

This post was originally published on this site

© Terrence Horan


The AstraZeneca PLC ADR AZN shed 0.59% to $50.56 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.25% to 13,036.43 and Dow Jones Industrial Average DJIA falling 0.29% to 31,008.69. AstraZeneca PLC ADR closed $14.38 short of its 52-week high ($64.94), which the company achieved on July 20th.

The ADR demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. ABBV rose 1.63% to $109.02, Amgen Inc. AMGN fell 0.39% to $237.57, and Gilead Sciences Inc. GILD fell 0.84% to $62.51. Trading volume (11.7 M) eclipsed its 50-day average volume of 10.5 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading